CNBX Pharmaceuticals Inc (CNBX)
0.0112
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
CNBX Pharmaceuticals Total Liabilities (Quarterly): 2.522M for Feb. 29, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 2.522M |
November 30, 2023 | 2.482M |
August 31, 2023 | 2.516M |
May 31, 2023 | 2.572M |
February 28, 2023 | 2.474M |
November 30, 2022 | 2.584M |
August 31, 2022 | 2.444M |
May 31, 2022 | 2.148M |
February 28, 2022 | 1.786M |
November 30, 2021 | 1.493M |
August 31, 2021 | 1.273M |
May 31, 2021 | 1.47M |
February 28, 2021 | 1.184M |
November 30, 2020 | 0.4427M |
August 31, 2020 | 0.4548M |
May 31, 2020 | 0.4301M |
February 29, 2020 | 0.4196M |
November 30, 2019 | 0.4405M |
August 31, 2019 | 0.4389M |
May 31, 2019 | 0.4541M |
February 28, 2019 | 0.3762M |
November 30, 2018 | 0.4127M |
August 31, 2018 | 0.5394M |
May 31, 2018 | 0.5233M |
February 28, 2018 | 0.4748M |
Date | Value |
---|---|
November 30, 2017 | 0.6398M |
August 31, 2017 | 0.6991M |
May 31, 2017 | 0.5862M |
February 28, 2017 | 0.7695M |
November 30, 2016 | 0.5134M |
August 31, 2016 | 0.4912M |
May 31, 2016 | 0.4914M |
February 29, 2016 | 0.4825M |
November 30, 2015 | 0.1205M |
August 31, 2015 | 0.3383M |
May 31, 2015 | 0.2033M |
February 28, 2015 | 0.067M |
November 30, 2014 | 0.0785M |
August 31, 2014 | 0.0741M |
May 31, 2014 | 0.0038M |
February 28, 2014 | 0.051M |
November 30, 2013 | 0.0501M |
August 31, 2013 | 0.1781M |
May 31, 2013 | 0.0735M |
February 28, 2013 | 0.0688M |
November 30, 2012 | 0.0641M |
August 31, 2012 | 0.049M |
May 31, 2012 | 0.0634M |
February 29, 2012 | 0.0594M |
November 30, 2011 | 0.0576M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.4196M
Minimum
Feb 2020
2.584M
Maximum
Nov 2022
1.501M
Average
1.481M
Median
Total Liabilities (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 5.197M |
Palatin Technologies Inc | 9.827M |
iBio Inc | 24.82M |
Theriva Biologics Inc | 14.61M |
Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.1639M |
Shareholders Equity (Quarterly) | -2.358M |
Debt to Equity Ratio | -0.548 |
Current Ratio | 0.065 |
Net Debt Paydown Yield | 25.21% |